Jacobs Solutions Inc. · J · FY2026 Q2 · Calendar Q2 2026

Jacobs Solutions Q2 FY2026: Beat and Raise, Stock Sells Off on Leverage Concerns

Jacobs Solutions delivered a second consecutive beat-and-raise in Q2 FY2026, with adjusted EPS up 22% YoY and organic net revenue growth of 9% on a record $27B backlog. Yet the market focused on what tempered that strength: book-to-bill decelerated from 2.0x to 1.2x net, net leverage rose to 2.1x above the 1.0-1.5x target, and adjusted free cash flow was a $272M outflow tied to PA Consulting transaction accounting. The stock fell 7.3% on 4.2x normal volume and drifted another 2.4% lower in the sessions that followed. The divergence between the operational beat and the market reaction highlights investor concerns about earnings quality, the sustainability of AI-driven growth, and the credibility of the deleveraging path.

Reported After market closeNYSEIndustrials $15.68B market cap
100quality score

Company context

Snapshot as of publication

Jacobs Solutions Inc. engages in the infrastructure and advanced facilities, and consulting businesses in the United States, Europe, Canada, India, Asia, Australia, New Zealand, the Middle East, and Africa. The company provides consulting, planning, architecture, design, engineering, and infrastructure delivery services including project, program, and construction management and long-term operation of facilities. It also offers consulting services for consumer and manufacturing, defense and security, energy and utilities, financial services, government, health and life sciences, and transport sectors. The company was founded in 1947 and is headquartered in Dallas, Texas.

Earnings scorecard

Reported versus consensus
Reported EPS $1.75 Consensus $2
EPS surprise +7.4% Reported versus consensus
Reported revenue $2.33B Consensus $2.28B
Revenue surprise +2.2% Reported versus consensus

Earnings History

Estimate Beat Miss Match
J EPS earnings history estimate and actual scatter chart 8 reported fiscal quarters and 4 future estimate-only quarters. Q4 '23 estimate $2.02 Q4 '23 actual $1.90, miss Q1 '24 estimate $1.50 Q1 '24 actual $2.02, beat Q2 '24 estimate $1.85 Q2 '24 actual $1.91, beat Q3 '24 estimate $1.96 Q3 '24 actual $1.96, match Q3 '25 estimate $1.53 Q3 '25 actual $1.62, beat Q4 '25 estimate $1.68 Q4 '25 actual $1.75, beat Q1 '26 estimate $1.52 Q1 '26 actual $1.53, match Q2 '26 estimate $1.63 Q2 '26 actual $1.75, beat Q3 '26 estimate $1.84 Q4 '26 estimate $2.13 Q1 '27 estimate $1.83 Q2 '27 estimate $1.88

Analyst Consensus ?

ConsensusBuy37 ratings
Bullish2362.2%
Neutral1437.8%
Bearish00.0%

Analyst 52W Price Targets

$132.75Previous close
$137Low
$156.32Average
$175High

Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Jul 31, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
RBC Capital Outperform OutperformMaintainJul 22, 2026
Truist Securities Hold HoldMaintainJul 2, 2026
Wells Fargo Equal Weight Equal WeightMaintainMay 7, 2026
Keybanc Overweight OverweightMaintainMay 6, 2026
Citigroup Buy BuyMaintainMay 6, 2026
Baird Neutral NeutralMaintainApr 13, 2026
B of A Securities Neutral NeutralMaintainNov 21, 2025
Barclays Overweight OverweightMaintainOct 20, 2025
UBS Buy BuyMaintainAug 6, 2025
Benchmark Hold BuyDowngradeNov 20, 2024
William Blair Market Perform OutperformDowngradeMay 8, 2024
Argus Research Buy BuyMaintainMar 14, 2024
Raymond James Market Perform OutperformDowngradeNov 22, 2023
Stifel Buy BuyMaintainNov 21, 2023
TD Cowen Outperform OutperformMaintainAug 10, 2023
Credit Suisse Outperform OutperformMaintainAug 9, 2023
Bernstein Outperform OutperformMaintainMay 10, 2023
DA Davidson Buy BuyMaintainNov 26, 2019
Bank of America Buy BuyMaintainNov 26, 2019
Cowen & Co. Outperform OutperformMaintainJan 28, 2019
MKM Partners Buy BuyMaintainNov 21, 2018
Seaport Global Buy BuyMaintainNov 15, 2018
Vertical Research Buy HoldUpgradeMay 9, 2018
Macquarie Neutral UnderperformUpgradeMay 9, 2018
Argus Buy HoldUpgradeMay 5, 2018
Deutsche Bank Buy HoldUpgradeMar 29, 2018
Goldman Sachs Neutral SellUpgradeJan 31, 2018
Jefferies Hold BuyDowngradeDec 13, 2016
Johnson Rice Hold AccumulateDowngradeAug 11, 2016
Standpoint Research Hold BuyDowngradeApr 14, 2016
JP Morgan Neutral NeutralMaintainJun 12, 2015
Stifel Nicolaus Buy BuyMaintainApr 29, 2015
CLSA Outperform BuyMaintainApr 13, 2015
FBR Capital Market Perform Market PerformMaintainFeb 2, 2015
Stephens & Co. Overweight OverweightMaintainDec 20, 2013
GARP Research Buy BuyMaintainMar 28, 2013
Gilford Securities Buy BuyMaintainJan 10, 2013
Show less

Named analyst price targets

Upside is calculated against the persisted previous close $132.75. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
Truist FinancialJamie Cook$149$124.63 +12.2%Jul 2, 2026
BernsteinChad Dillard$163$124.12 +22.8%Jun 11, 2026
RBC CapitalSabahat Khan$169$124.75 +27.3%May 6, 2026
KeyBancSangita Jain$150$136.74 +13.0%May 6, 2026
Goldman SachsAdam Bubes$163$143.33 +22.8%Feb 4, 2026
UBSSteven Fisher$175$137.42 +31.8%Feb 4, 2026
RBC CapitalAnalyst unavailable$160$137.85 +20.5%Feb 4, 2026
Robert W. BairdAndrew Wittmann$143$132.91 +7.7%Feb 4, 2026
Wells FargoAnalyst unavailable$137$140.09 +3.2%Jan 23, 2026
KeyBancAnalyst unavailable$154$137.67 +16.0%Jan 7, 2026
Goldman SachsAnalyst unavailable$158$128.77 +19.0%Nov 24, 2025
Truist FinancialAnalyst unavailable$152$129.17 +14.5%Nov 21, 2025
RBC CapitalAnalyst unavailable$156$128.06 +17.5%Nov 21, 2025
Wells FargoAnalyst unavailable$130$129.17 -2.1%Nov 21, 2025
Robert W. BairdAnalyst unavailable$146$129.17 +10.0%Nov 21, 2025
Wells FargoAnalyst unavailable$160$153.2 +20.5%Nov 13, 2025
BarclaysAdam Seiden$160$155.39 +20.5%Oct 20, 2025
KeyBancAnalyst unavailable$170$155.39 +28.1%Oct 20, 2025
Truist FinancialAnalyst unavailable$163$155.31 +22.8%Oct 8, 2025
Robert W. BairdAndrew Wittmann$161$148.48 +21.3%Aug 27, 2025
CitigroupAndrew Kaplowitz$166$143.54 +25.0%Oct 22, 2024
Raymond JamesBrian Gesuale$160$138.91 +20.5%Oct 4, 2024
Stifel NicolausBert Subin$160$149.71 +20.5%Apr 2, 2024
Truist FinancialJamie Cook$154$150.64 +16.0%Mar 13, 2024
RBC CapitalAnalyst unavailable$155$127.91 +16.8%Aug 4, 2022
CitigroupAnalyst unavailable$151$129.52 +13.7%Aug 2, 2022
Credit SuisseAnalyst unavailable$154$129.52 +16.0%Aug 2, 2022
Stifel NicolausBert Subin$158$124.36 +19.0%Jun 29, 2022
CitigroupAndrew Kaplowitz$163$127.74 +22.8%Feb 9, 2022
Show less

Track every rating change on J the moment it posts. Free to start.

Start free

Market reaction

event-close to next-session close
Stock move -7.3% Event window
SPY move +1.4% Same window
Abnormal move -8.7% Stock minus SPY
Volume 4.2× Versus trailing sessions
Subsequent drift -2.4% Up to 20 sessions
JSPY benchmark

Follow J with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Transcript intelligence

What changed

FY2026 guidance was raised for the second consecutive quarter: net revenue growth lifted from 6.5-10% to 8-10.5% and adjusted EPS from $6.95-$7.30 to $7.10-$7.35. Backlog grew from $26.3B to a record $27B, but book-to-bill decelerated from 2.0x in Q1 to 1.4x gross and 1.2x net in Q2. The data-center business grew over 100% YoY and now represents 3-4% of revenue, while the AI infrastructure pipeline grew 400% with visibility through 2027-2028. PA Consulting reached 100% ownership, delivering 12-20% margin expansion and over $20M in identified annual cost synergies. Net leverage rose to 2.1x, above the 1.0-1.5x target range, and adjusted free cash flow was an outflow of $272M due to GAAP treatment of the PA Consulting transaction proceeds.

Guidance delta

Raised for the second consecutive quarter. Adjusted net revenue growth guidance lifted from 6.5-10% to 8-10.5%; adjusted EPS from $6.95-$7.30 to $7.10-$7.35. EBITDA margin targeted at approximately 15% in Q3 and above 16% in Q4 FY2026. Management plans to reduce net leverage below 2.0x by fiscal year-end while maintaining an aggressive share repurchase program.

Key takeaways

  • Adjusted EPS of $1.75 beat the $1.63 consensus by 7.4%; revenue of $2.33B beat by 2.2%
  • Organic net revenue grew 9% YoY; adjusted EPS up 22% YoY
  • Backlog hit a record $27B; book-to-bill slowed to 1.2x net from 2.0x in Q1
  • FY2026 guidance raised again: revenue growth 8-10.5%, adjusted EPS $7.10-$7.35
  • Data center business grew over 100% YoY; AI infrastructure pipeline up 400% with visibility through 2027-2028
  • PA Consulting delivering 12-20% margin expansion and $20M+ in annual cost synergies

Management priorities

  • Realize $20M+ annual cost synergies from PA Consulting integration
  • Reduce net leverage below 2.0x by fiscal year-end
  • Achieve EBITDA margin of approximately 15% in Q3 and above 16% in Q4 FY2026
  • Accelerate AI-enabled digital twin and AI-infrastructure services
  • Continue aggressive share repurchase program
  • Expand footprint in defense, energy, and transportation through combined PA Consulting capabilities

Related earnings events

Industrials

Sources

  1. Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
  2. FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
  3. Polygon adjusted daily market bars · 2026-07-31T08:51:54.789057+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-31T08:51:54.786330+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.